Hansa Biopharma announces positive full results from 15-HMedIdeS-09 Phase 2 study and comparative analysis of imlifidase in patients with Guillain-Barré Syndrome

Lund, Sweden, 17 December 2024. Hansa Biopharma, “Hansa” (Nasdaq Stockholm:…

Buy-back of shares in MTG during week 50, 2024

During the period between 9 December and 13 December 2024 Modern…

Fondia Plc: Share repurchase 17.12.2024

Fondia Plc Company release 17.12.2024 at 6.45 p.m. EET  …

Grant of new warrants in connection with loan

MapsPeople A/S | Grant of warrantsCompany Announcement No. 29 -…

TokenBuilder Releases 2025 Forecast on AI Integration and Fair Token Offerings

TokenBuilder Releases 2025 Forecast on AI Integration and Fair Token Offerings - BitcoinWorld Skip to…

Kotak unveils Kotak BizLabs to accelerate and empower Startups, ET BFSI

Kotak Mahindra BankKotak Mahindra Bank has launched the Kotak BizLabs accelerator programme under its CSR…

Flipster and OverProtocol Announce Partnership with $200,000 USDT Giveaway

Flipster and OverProtocol Announce Partnership with $200,000 USDT Giveaway - BitcoinWorld Skip to content Home…

Transactions of executives and related parties in Asetek shares

According to the Market Abuse Regulation art. 19, Asetek A/S…

Novotech Named a Fierce CRO Award Winner in the Excellence in Clinical Trial Management and Global Operations Categories

Sydney, Australia:  Novotech, the global full-service clinical Contract Research Organization (CRO)…

Exercise of the overallotment option in Apotea and end of the stabilisation period in advance

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR…

Recent Comments

No comments to show.
logo

Hello, We’re content writer who is fascinated by content fashion, celebrity and lifestyle. We helps clients bring the right content to the right people.

Newsletter

- Sponsored Ad - Advertisement